Literature DB >> 3195815

Qualitative and quantitative drug-susceptibility tests in mycobacteriology.

L Heifets1.   

Abstract

Qualitative methods of susceptibility testing have been employed widely around the world during the last 37 years and have proved to be a generally reliable tool to guide the chemotherapy of tuberculosis with conventional antituberculosis drugs. However, we believe there is a need now for application of modern quantitative methods to mycobacteriology: (1) for susceptibility testing of Mycobacterium avium complex, (2) for evaluation of the bactericidal activity of the antimycobacterial drugs, (3) for evaluation of the inhibitory and bactericidal activity of drug combinations, (4) for search and evaluation of new drugs against both Mycobacterium tuberculosis and Mycobacterium avium complex. Newly developed technology (radiometric automated bacterial growth recording in the BACTEC system) has opened new opportunities for development of quantitative methods in mycobacteriology using liquid culture medium. This paper analyzes the potential applications to mycobacteriology of 4 quantitative criteria: Minimal Inhibitory Concentration (MIC), Minimal Bactericidal Concentration (MBC), Fractional Inhibitory Concentration (FIC), and Fractional Bactericidal Concentration (FBC).

Entities:  

Mesh:

Year:  1988        PMID: 3195815     DOI: 10.1164/ajrccm/137.5.1217

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  43 in total

1.  In vitro susceptibility of Mycobacterium kansasii to clarithromycin.

Authors:  J Biehle; S J Cavalieri
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Mycobacterium malmoense in Italy: the modern Norman invasion?

Authors:  E Tortoli; C Piersimoni; A Bartoloni; C Burrini; A P Callegaro; G Caroli; D Colombrita; A Goglio; A Mantella; C P Tosi; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

3.  Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.

Authors:  N Galí; J Domínguez; S Blanco; C Prat; F Alcaide; P Coll; V Ausina
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  N Galí; J Domínguez; S Blanco; C Prat; M D Quesada; L Matas; V Ausina
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.

Authors:  Stellah G Mpagama; Norah Ndusilo; Suzanne Stroup; Happiness Kumburu; Charles A Peloquin; Jean Gratz; Eric R Houpt; Gibson S Kibiki; Scott K Heysell
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

6.  Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens.

Authors:  N García-Sierra; A Lacoma; C Prat; L Haba; J Maldonado; J Ruiz-Manzano; P Gavin; S Samper; V Ausina; J Domínguez
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

Review 7.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.

Authors:  Florian P Maurer; Vera L Bruderer; Claudia Ritter; Claudio Castelberg; Guido V Bloemberg; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

9.  Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.

Authors:  Gopinath Viswanathan; Sangya Yadav; Tirumalai R Raghunand
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

10.  GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.

Authors:  A Lacoma; N Garcia-Sierra; C Prat; J Ruiz-Manzano; L Haba; S Rosés; J Maldonado; J Domínguez
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.